Modulation of alternative splicing contributes to cancer development: Focusing on p53 isoforms, p53β and p53γ

Cell Death and Differentiation

Volumn 21, Issue 9, 2014, Pages 1347-1349

  Solomon, H ^a   Sharon, M ^a   Rotter, V ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; TP53 PROTEIN, HUMAN;

ALTERNATIVE RNA SPLICING; GENETICS; HUMAN;

ALTERNATIVE SPLICING; HUMANS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84905817119     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2014.99     Document Type: Editorial

References (20)

1. Leff SE, Rosenfeld MG, Evans RM. Annu Rev Biochem 1986; 55: 1091-1117.
2. Blencowe BJ. Cell 2006; 126: 37-47.
3. Olsson A, Manzl C, Strasser A, Villunger A. Cell Death Differ 2007; 14: 1561-1575.
4. Goldstein I et al. Cancer Gene Ther 2011; 18: 2-11.
5. Beckerman R, Prives C. Cold Spring Harb Perspect Biol 2010; 2: a000935.
6. Marcel V et al. Cell Death Differ 2011; 18: 1815-1824.
7. Wolf D, Harris N, Goldfinger N, Rotter V. Molecular Cell Biol 1985; 5: 127-132.
8. Arai N et al. Molecular Cell Biol 1986; 6: 3232-3239.
9. Wolkowicz R, Peled A, Elkind NB, Rotter V. Proc Natl Acad Sci USA 1995; 92: 6842-6846.
10. Bourdon JC et al. Genes Dev 2005; 19: 2122-2137.
11. Surget S, Khoury MP, Bourdon JC. Onco Targets Ther 2013; 7: 57-68.
12. Courtois S et al. Oncogene 2002; 21: 6722-6728.
13. Fujita K et al. Nat Cell Biol 2009; 11: 1135-1142.
14. Brosh R, Rotter V. Nat Rev Cancer 2009; 9: 701-713.
15. Bourdon JC et al. Breast Cancer Res 2011; 13: R7.
16. Avery-Kiejda KA et al. Carcinogenesis 2014; 35: 586-596.
17. Hofstetter G et al. Br J Cancer 2011; 105: 1593-1599.
18. Matera AG, Wang Z. Nat Rev Mol Cell Biol 2014; 15: 108-121.
19. Dehm SM. Cancer Res 2013; 73: 5309-5314.
20. Ladomery M. Int J Cell Biol 2013; 2013: 463786.